Treatment of Post-Traumatic Carotid-Cavernous Fistulas with the Willis Covered Stent A Preliminary Prospective Study

Treatment of Post-Traumatic Carotid-Cavernous Fistulas with the Willis Covered Stent A Preliminary Prospective Study
复制标题

DOI:
10.1177/159101991201800208
复制
发表时间:
2012-06-01
影响因子:
1.7
通讯作者:
Wu, G.
Wu, G.
中科院分区:
医学4区
文献类型:
--
作者:
Wang, Y-L.;Ma, J.;Wu, G.

文献摘要

被引文献

相似文献

我们描述了我们在颈动脉海绵窦瘘(CCF)患者中使用Willis覆膜支架的可行性的初步经验。11例创伤后CCFs转诊接受Willis覆膜支架治疗的患者入选本前瞻性研究,随后在我院进行随访。收集了技术成功率、初始和最终血管造影结果、死亡率、发病率和最终临床结局的数据,并在1个月、3个月、6个月和12个月以及此后每年进行随访。支架置入后的血管造影结果显示,8例患者的10个CCF完全闭塞,3例不完全闭塞。术中或术后均未发生不良事件。血管造影随访(平均14.73 ± 6.77个月)显示所有患者均完全闭塞,无明显支架内狭窄。临床随访(平均17.73 +/- 6.48个月)显示10例患者完全恢复,1例改善。这些初步结果表明,使用Willis覆膜支架是一种可行的手术,因此可以作为CCF的替代治疗。需要更长时间的随访评估和扩大的临床试验。
We describe our preliminary experience on the feasibility of using the Willis covered stent in patients with carotid-cavernous fistulas (CCFs).Eleven consecutive patients with post-traumatic CCFs referred for treatment with Willis covered stents were enrolled into this prospective study, and were subsequently followed-up at our hospital. Data on technical success, initial and final angiographic results, mortality, morbidity and final clinical outcome, was collected, with follow-up performed at one, three, six and 12 months, and yearly thereafter.Deployment of the covered stents was technically successful in all patients. Angio graphic results following stent placement showed a complete occlusion in eight patients with ten CCFs, and an incomplete occlusion in three. No adverse events occurred either during or after the procedure. Angiographic follow-up (mean 14.73 +/- 6.77 months) revealed complete occlusion and no obvious in-stent stenosis in all patients. Clinical follow-up (mean 17.73 +/- 6.48 months) demonstrated full recovery in ten patients, and improvement in one.These preliminary results indicate that the use of the Willis covered stent is a feasible procedure, and that it may therefore serve as an alternative treatment for CCFs. Longer follow-up assessments and an expanded clinical trial are needed.